AI Article Synopsis

  • The study investigates the relationship between the Ser680Asn polymorphism of the FSH receptor and AMH levels in women undergoing IVF/ICSI, aiming to identify predictive indicators for treatment outcomes.
  • 32 women participated, divided into two groups based on the type of medication received (rFSH or hMG), with serum and follicular fluid AMH levels measured during the treatment cycle.
  • Results indicated no significant differences in AMH levels based on the FSH receptor genotype; however, women with the Ser allele tended to have more follicles and mature oocytes, suggesting a potential link to fertility outcomes that could inform personalized treatment strategies.

Article Abstract

Background: Several studies have investigated on the polymorphism Ser680Asn of FSHR and its use as a predictive indicator of response to an IVF/ICSI protocol. Furthermore, measurement of AMH in serum and follicular fluid is a useful prognostic indicator for the outcome of an assisted reproduction attempt. The purpose of this study is to examine the FSH receptor Ser680Asn polymorphism in combination with AMH levels in both serum and follicular fluid, on the day of oocyte collection.

Materials And Methods: A total of 32 women who underwent IVF/ICSI were included. Women were grouped into 2 groups: those who received rFSH ( = 11) and those who received hMG ( = 21). Serum AMH was measured on day 3 of the cycle, and AMH in the follicular fluid on the day of oocyte retrieval; the same day peripheral blood was collected for the genotyping of Ser680Asn.

Results: No statistical significant difference was found between serum AMH and follicular fluid AMH regarding the FSH receptor genotype for the Ser680Asn polymorphism. Regarding the sAMH/ffAMH ratio in the 3 genotypes, the value was lower in Asn/Asn women than Ser/Ser and Ser/Asn, but no statistical difference was obtained. Women who carry the Ser allele have a higher number of follicles, retrieved oocytes, and mature oocytes than women who do not contain the Ser allele. Women with AMH < 2.22 ng/ml presented lower AMH follicular fluid levels and lower serum AMH/follicular fluid AMH ratio in a statistically significant manner. Concerning the genotype for the polymorphism Ser680Asn of FSHR in relation to AMH levels, no statistically significant differences were found.

Conclusions: The identification of polymorphisms, such as Ser680Asn of FSHR, along with the determination of endocrine markers in the follicular fluid, such as AMH, could lead at some point, to the personalized therapy setting per woman.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889364PMC
http://dx.doi.org/10.1155/2021/8685158DOI Listing

Publication Analysis

Top Keywords

follicular fluid
28
amh follicular
16
amh
12
ser680asn fshr
12
fluid amh
12
fluid
8
polymorphism ser680asn
8
serum follicular
8
fsh receptor
8
ser680asn polymorphism
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!